Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05138458 |
| Title | A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL (IMAGINE) |
| Acronym | IMAGINE |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Myeloid Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| Dana-Farber/Mass General Brigham Cancer Care | Boston | Massachusetts | 02215 | United States | Details | |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | United States | Details | |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| University of Virginia Comprehensive Cancer Center | Charlottesville | Virginia | 22908 | United States | Details |